Neoplas Med Secures $18M Investment to Advance Cold Plasma Wound Care Technology

Key Highlights:

– Neoplas Med GmbH, a medical technology company based in Greifswald, has secured an $18M investment from Niterra Ventures Company to advance and expand its groundbreaking cold plasma wound care technology.

– This latest round brings Niterra’s total investment in Neoplas Med to $25M, following previous investments in 2022 and 2023.

Revolutionizing Wound Care with Cold Plasma

Neoplas Med is a leader in cold plasma technology for medical applications. As the only European manufacturer with European Medical Device Regulation (MDR) certification for cold plasma products, the company has made significant strides in the field. Its patented kINPen® MED is a state-of-the-art “plasma pen” that uses argon-based cold plasma to speed up the healing of wounds. This innovative treatment is already widely used in top clinics across Europe and the Middle East. Compared to traditional methods, Neoplas Med's cold plasma therapy offers several key advantages:

Where to Find the Best Deals on Hoka Shoes

Are you a runner? More specifically, a road runner? Hoka was built for that. Meaning “to fly” in Maori, Hoka was founded in 2009 so that runners could get the ultimate experience with optimum cushioning and stability. Less than 15 years after its founding, Hoka is bringing in revenues topping a billion dollars a year, so it’s clear that people are loving this brand. But with quality comes high prices, and Hoka is no doubt in the high end price-wise. So we’ve rounded up the best stores to find the best deals for Hoka.

Shop the Best Deals

• Accelerated Healing: Clinical trials indicate that kINPen® MED can reduce wound healing time by up to 50% compared to conventional treatments.

• Painless and Safe: The argon cold plasma jet is virtually painless, with no known side effects or risk of resistance development.

• Versatility: The technology is effective for treating a range of wounds, including chronic and infected ones.

This new investment will allow Neoplas Med to:

• Enhance its technology: Further refine and expand the capabilities of its cold plasma platform.

• Expand internationally: Increase its presence in key markets, especially the US, Europe, and the Middle East.

• Boost production: Scale up production to meet rising demand for its advanced wound care solutions.